Targeting iNKT Cells for the Treatment of Sickle Cell Disease

Clinical Immunology - United States
doi 10.1016/j.clim.2011.03.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

5626884 Treatment of Sickle Cell Disease

Transfusion Science
1997English

NF-κB Is Activated in CD4+ iNKT Cells by Sickle Cell Disease and Mediates Rapid Induction of Adenosine A2A Receptors

PLoS ONE
Multidisciplinary
2013English

Advances in the Treatment of Sickle Cell Disease

Mayo Clinic Proceedings
Medicine
2018English

APS Sickle Cell Disease Conference Mini-Review: Targeting Pain at Its Source in Sickle Cell Disease

American Journal of Physiology - Regulatory Integrative and Comparative Physiology
Physiology
2018English

Treatment of Dental Complications in Sickle Cell Disease

Cochrane Database of Systematic Reviews
2016English

Rifaximin for Sickle Cell Disease

American Journal of Hematology
Hematology
2019English

Steroid Treatment in Children With Sickle-Cell Disease

Haematologica
Hematology
2007English

Sickle Cell Disease

Revista Brasileira de Hematologia e Hemoterapia
2011English

The Sickle Cell Disease Implementation Consortium: Translating Evidence-Based Guidelines Into Practice for Sickle Cell Disease

American Journal of Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy